D
ORIC Pharmaceuticals, Inc. ORIC
$10.75 $0.100.94% NASDAQ
Recommendation
Prev Close
$10.65
Volume
208,415
Avg Vol (90D)
1,320,013
Market Cap
$1.04B
Dividend & Yield
--
52-Week Range
$3.90 - $14.93
P/E (TTM)
--
EPS (TTM)
-$1.73
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Oric Pharmaceuticals (ORIC, $10.65) Aroon Indicator entered a Downtrend on December 02, 2025.
12/3/2025 - Tickeron - Stocks
Oric Pharmaceuticals (ORIC, $10.65) RSI Indicator left the oversold zone on December 02, 2025
12/3/2025 - Tickeron - Stocks
Critical Comparison: Oric Pharmaceuticals (NASDAQ:ORIC) and LENZ Therapeutics (NASDAQ:LENZ)
12/3/2025 - Ticker Report
Does ORIC (ORIC) Have the Scientific Depth to Turn Enozertinib Data Into Lasting Value?
12/3/2025 - Simply Wall St
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Moderate Buy" from Analysts
12/3/2025 - MarketBeat
Oric Pharmaceuticals (ORIC, $11.15) Aroon Indicator entered a Downtrend on December 01, 2025.
12/2/2025 - Tickeron - Stocks
ORIC Pharmaceuticals (ORIC): Assessing Valuation as New Enozertinib Clinical Data Sparks Investor Interest
12/2/2025 - Simply Wall St
ORIC Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
12/1/2025 - Globe Newswire
Oric Pharmaceuticals (ORIC, $11.88) Aroon Indicator entered a Downtrend on November 28, 2025.
11/29/2025 - Tickeron - Stocks
Oric Pharmaceuticals (ORIC, $11.82) Aroon Indicator entered a Downtrend on November 26, 2025.
11/27/2025 - Tickeron - Stocks
Oric Pharmaceuticals (ORIC, $11.62) Aroon Indicator entered a Downtrend on November 25, 2025.
11/26/2025 - Tickeron - Stocks
Oric Pharmaceuticals (ORIC, $11.79) Aroon Indicator entered a Downtrend on November 24, 2025.
11/25/2025 - Tickeron - Stocks
ORIC Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
11/24/2025 - Globe Newswire
Oric Pharmaceuticals (NASDAQ:ORIC) Lowered to Sell Rating by Wall Street Zen
11/24/2025 - Ticker Report
Can New Prostate Cancer Data Reinforce ORIC (ORIC)'s Position as an Oncology Innovator?
11/23/2025 - Simply Wall St
Oric Pharmaceuticals (NASDAQ:ORIC) Rating Lowered to Sell at Wall Street Zen
11/23/2025 - MarketBeat
Oric Pharmaceuticals (ORIC, $11.62) Aroon Indicator entered a Downtrend on November 21, 2025.
11/22/2025 - Tickeron - Stocks
A Closer Look at ORIC Pharmaceuticals (ORIC) Valuation After Encouraging New Phase 1b Trial Results
11/22/2025 - Simply Wall St
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Should You Buy?
11/21/2025 - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated at Evercore ISI
11/21/2025 - MarketBeat
Oric Pharmaceuticals (ORIC, $11.48) Aroon Indicator entered a Downtrend on November 20, 2025.
11/21/2025 - Tickeron - Stocks
Oric Pharmaceuticals (ORIC, $11.48) Aroon Indicator entered a Downtrend on November 19, 2025.
11/20/2025 - Tickeron - Technical Analysis
ORIC Pharmaceuticals (ORIC) Initiates Coverage with Outperform Rating ORIC Stock News
11/20/2025 - GuruFocus
Oric Pharmaceuticals initiated with bullish view at Evercore ISI, here's why
11/20/2025 - The Fly
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
11/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$146.82M
EBIT (TTM)
-$148.02M
Net Income (TTM)
-$135.27M
Balance Sheet
Total Assets (Q)
$431.19M
Total Debt (Q)
$7.40M
Total Liabilities (Q)
$24.27M
Book Value Per Share (Q)
$4.18
Cash Flow
Cash from Operations (TTM)
-$116.54M
Cash from Investing (TTM)
-$122.36M
Cash from Financing (TTM)
$244.34M
Net Change in Cash (TTM)
$5.44M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.78
7-Day Total Return
-7.49%
30-Day Total Return
-14.68%
60-Day Total Return
-1.47%
90-Day Total Return
-3.85%
Year to Date Total Return
30.15%
1-Year Total Return
11.98%
2-Year Total Return
27.22%
3-Year Total Return
167.41%
5-Year Total Return
-69.85%
52-week Low
Apr 09, 2025 - $3.90
52-week High
Oct 07, 2025 - $14.93
Valuation
Market Cap
$1.04B - Small Cap
Enterprise Value
$757.45M
Price/Sales (TTM)
--
Price/Book (Q)
2.55
Dividends and Shares
Shares Outstanding
98.95
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.oricpharma.com
Phone Number
650 388 5600
Address
240 East Grand Avenue
South San Francisco, CA 94080
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States... more
NASDAQ 12/03/2025 12:28PM Eastern Quotes delayed